Roschier represented Karolinska Development in approx. USD 50 million offer of convertible bonds. The convertibles will be listed on Nasdaq Stockholm and as a result Karolinska Development will be one of the few companies in Sweden with convertible bonds listed on Nasdaq Stockholm.

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into differentiated products that can be partnered.